SPDR S&P Pharmaceuticals ETF (XPH)
NYSEARCA: XPH · Real-Time Price · USD
41.23
+0.47 (1.15%)
Jul 2, 2025, 4:00 PM - Market closed
XPH Holdings List
As of Jul 1, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | RPRX | Royalty Pharma plc | 4.01% |
2 | PFE | Pfizer Inc. | 3.90% |
3 | VTRS | Viatris Inc. | 3.89% |
4 | MRK | Merck & Co., Inc. | 3.88% |
5 | ELAN | Elanco Animal Health Incorporated | 3.85% |
6 | JNJ | Johnson & Johnson | 3.82% |
7 | PRGO | Perrigo Company plc | 3.82% |
8 | OGN | Organon & Co. | 3.80% |
9 | JAZZ | Jazz Pharmaceuticals plc | 3.77% |
10 | CORT | Corcept Therapeutics Incorporated | 3.70% |
11 | TARS | Tarsus Pharmaceuticals, Inc. | 3.70% |
12 | LLY | Eli Lilly and Company | 3.65% |
13 | ZTS | Zoetis Inc. | 3.64% |
14 | AXSM | Axsome Therapeutics, Inc. | 3.63% |
15 | BMY | Bristol-Myers Squibb Company | 3.61% |
16 | PBH | Prestige Consumer Healthcare Inc. | 3.59% |
17 | HRMY | Harmony Biosciences Holdings, Inc. | 2.79% |
18 | PCRX | Pacira BioSciences, Inc. | 2.52% |
19 | ANIP | ANI Pharmaceuticals, Inc. | 2.33% |
20 | AMRX | Amneal Pharmaceuticals, Inc. | 2.23% |
21 | SUPN | Supernus Pharmaceuticals, Inc. | 2.05% |
22 | INVA | Innoviva, Inc. | 1.99% |
23 | OCUL | Ocular Therapeutix, Inc. | 1.96% |
24 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.94% |
25 | XERS | Xeris Biopharma Holdings, Inc. | 1.93% |
26 | EWTX | Edgewise Therapeutics, Inc. | 1.86% |
27 | LGND | Ligand Pharmaceuticals Incorporated | 1.83% |
28 | HROW | Harrow, Inc. | 1.77% |
29 | COLL | Collegium Pharmaceutical, Inc. | 1.56% |
30 | WVE | Wave Life Sciences Ltd. | 1.41% |
31 | LQDA | Liquidia Corporation | 1.40% |
32 | CRMD | CorMedix Inc. | 1.33% |
33 | ARVN | Arvinas, Inc. | 1.12% |
34 | TRVI | Trevi Therapeutics, Inc. | 1.00% |
35 | EOLS | Evolus, Inc. | 0.96% |
36 | NUVB | Nuvation Bio Inc. | 0.88% |
37 | MNMD | Mind Medicine (MindMed) Inc. | 0.87% |
38 | PAHC | Phibro Animal Health Corporation | 0.87% |
39 | LENZ | LENZ Therapeutics, Inc. | 0.84% |
40 | EYPT | EyePoint Pharmaceuticals, Inc. | 0.80% |
41 | ELVN | Enliven Therapeutics, Inc. | 0.79% |
42 | ZVRA | Zevra Therapeutics, Inc. | 0.49% |
43 | - | SSI US GOV MONEY MARKET CLASS | 0.18% |
As of Jul 1, 2025